Redsense Medical AB Statistics
Total Valuation
RDSNF has a market cap or net worth of 8.17 million. The enterprise value is 6.80 million.
| Market Cap | 8.17M |
| Enterprise Value | 6.80M |
Important Dates
The next estimated earnings date is Thursday, February 19, 2026.
| Earnings Date | Feb 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 16.44M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +267.27% |
| Shares Change (QoQ) | -90.01% |
| Owned by Insiders (%) | 15.02% |
| Owned by Institutions (%) | 17.56% |
| Float | 4.78M |
Valuation Ratios
The trailing PE ratio is 255.86.
| PE Ratio | 255.86 |
| Forward PE | n/a |
| PS Ratio | 2.42 |
| PB Ratio | 2.14 |
| P/TBV Ratio | 2.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.71, with an EV/FCF ratio of -22.16.
| EV / Earnings | 212.97 |
| EV / Sales | 1.91 |
| EV / EBITDA | 34.71 |
| EV / EBIT | 41.57 |
| EV / FCF | -22.16 |
Financial Position
The company has a current ratio of 6.45
| Current Ratio | 6.45 |
| Quick Ratio | 4.57 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 40.61 |
Financial Efficiency
Return on equity (ROE) is 0.85% and return on invested capital (ROIC) is 2.58%.
| Return on Equity (ROE) | 0.85% |
| Return on Assets (ROA) | 2.29% |
| Return on Invested Capital (ROIC) | 2.58% |
| Return on Capital Employed (ROCE) | 4.07% |
| Weighted Average Cost of Capital (WACC) | 6.13% |
| Revenue Per Employee | 844,839 |
| Profits Per Employee | 7,986 |
| Employee Count | 4 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 2.15 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.34 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 229 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, RDSNF had revenue of 3.38 million and earned 31,944 in profits. Earnings per share was 0.00.
| Revenue | 3.38M |
| Gross Profit | 2.00M |
| Operating Income | 155,156 |
| Pretax Income | 31,944 |
| Net Income | 31,944 |
| EBITDA | 185,826 |
| EBIT | 155,156 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 1.30 million in cash and n/a in debt, with a net cash position of 1.30 million.
| Cash & Cash Equivalents | 1.30M |
| Total Debt | n/a |
| Net Cash | 1.30M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.81M |
| Book Value Per Share | 0.23 |
| Working Capital | 2.25M |
Cash Flow
In the last 12 months, operating cash flow was -282,082 and capital expenditures -24,940, giving a free cash flow of -307,022.
| Operating Cash Flow | -282,082 |
| Capital Expenditures | -24,940 |
| Free Cash Flow | -307,022 |
| FCF Per Share | n/a |
Margins
Gross margin is 59.20%, with operating and profit margins of 4.59% and 0.95%.
| Gross Margin | 59.20% |
| Operating Margin | 4.59% |
| Pretax Margin | 0.95% |
| Profit Margin | 0.95% |
| EBITDA Margin | 5.50% |
| EBIT Margin | 4.59% |
| FCF Margin | n/a |
Dividends & Yields
RDSNF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -267.27% |
| Shareholder Yield | -267.27% |
| Earnings Yield | 0.39% |
| FCF Yield | -3.76% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RDSNF has an Altman Z-Score of 18.74 and a Piotroski F-Score of 5.
| Altman Z-Score | 18.74 |
| Piotroski F-Score | 5 |